苡樂股份有限公司
Update：2026/11/10
Industries
Main Industry
Lending and Investments
Main Product/Service
The 苡樂股份有限公司 Innovation Platform: Transforming Taiwan into a Base for Medical Device Innovation and Mass Production
The content above was translated by Ai
Founded Year
2017
Unified Business No.
61758097
Status
Active
Number of Employees
0
Total Paid-in
Capital
85,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
(Also known as: 苡樂拉法股份有限公司) 苡樂 invests in key medical device technologies to establish positions, initiates feasibility assessments and topic selection, and while biomedical managers accelerate product development, it strengthens organizational structures, introduces corporate governance, and completes business models, transforming technology into products to generate cash flow and enter the capital market. We believe that Taiwan's supply chain and clinical technology innovation energy can become a global innovation and mass production base for medical devices. 苡樂 invites capital, teams, technology, and market strategic partners to join the 苡樂 innovation platform through co-investment, to jointly build Taiwan's medical device industry.
The content above was translated by Ai
